UnitedHealth Group (UNH) Investor Day 2024 summary

Strategic response to funding and market pressures

• Navigated significant funding reductions and regulatory changes, including V28 adjustments and Part D reform, by refocusing operations, accelerating technology adoption, and aggressively managing costs.

• Maintained commitment to long-term growth targets despite short-term guidance being lower due to ongoing external pressures.

• Emphasized resilience, adaptability, and a refusal to compromise on quality or strategic investments for short-term gains.

• Continued to divest underperforming or obsolete businesses to align with evolving market needs.

• Reinforced a culture of performance, compassion, and innovation to drive sustainable growth.

Strategic direction and growth priorities

• Focus on five strategic growth areas: value-based care, benefits, pharmacy, financial services, and technology-led businesses, aiming to deliver integrated, patient-centered care and transform the consumer experience through technology and AI advancements.

• Committed to expanding value-based care, targeting tens of millions of Americans within the next decade, and integrating care across clinic, home, and virtual settings.

• Emphasizing simplicity, transparency, and innovation to meet rising consumer expectations and modernize healthcare access.

• Expanding individual exchange coverage to 30 states in 2025 and growing Medicaid and Medicare Advantage offerings, with a focus on benefit stability and serving vulnerable populations.

• Optum now serves over 100 million consumers and works with more than 100 health plans, integrating care across Medicare, Medicaid, commercial, and special needs populations.

Financial outlook and guidance

• 2025 revenue guidance: $450–$455 billion; operating earnings: $37.8–$38.8 billion; adjusted EPS: $29.50–$30.00.

• Long-term EPS growth target of 13%–16%, with two-thirds from operations and the rest from capital deployment.

• Optum expects double-digit revenue growth, with Optum Health targeting 8%–10% operating margins, Optum Insight 18%–22%, and Optum Rx 3%–5%.

• UnitedHealthcare projects 8%–10% long-term annual revenue growth, with stable operating margins and a gradually rising medical care ratio as public sector programs expand.

• Cash flows from operations projected at $32–$33 billion in 2025, with ongoing dividends and share repurchases contributing 3–5 percentage points to EPS growth.